Detailed information for compound 1768172

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 441.523 | Formula: C23H31N5O4
  • H donors: 6 H acceptors: 4 LogP: -1.39 Rotable bonds: 14
    Rule of 5 violations (Lipinski): 2
  • SMILES: NCCCC[C@@H](C(=O)O)NC(=O)c1ccc(c(c1)NC(=O)[C@H](CCc1ccccc1)N)N
  • InChi: 1S/C23H31N5O4/c24-13-5-4-8-19(23(31)32)27-21(29)16-10-12-17(25)20(14-16)28-22(30)18(26)11-9-15-6-2-1-3-7-15/h1-3,6-7,10,12,14,18-19H,4-5,8-9,11,13,24-26H2,(H,27,29)(H,28,30)(H,31,32)/t18-,19-/m0/s1
  • InChiKey: XPUCDWKMNQBXIH-OALUTQOASA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens endoplasmic reticulum aminopeptidase 2 Starlite/ChEMBL References
Homo sapiens endoplasmic reticulum aminopeptidase 1 Starlite/ChEMBL References
Homo sapiens leucyl/cystinyl aminopeptidase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi Peptidase family M1 containing protein endoplasmic reticulum aminopeptidase 1 941 aa 846 aa 29.3 %
Brugia malayi Peptidase family M1 containing protein endoplasmic reticulum aminopeptidase 2 960 aa 877 aa 31.0 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis alkaline phosphatase 0.3911 1 0.5
Echinococcus granulosus alkaline phosphatase 0.3911 1 0.5
Echinococcus multilocularis intestinal type alkaline phosphatase 0.3911 1 0.5
Schistosoma mansoni 23-cyclic-nucleotide 2-phosphodiesterase 0.2278 0.4519 0.1307
Echinococcus granulosus intestinal type alkaline phosphatase 1 0.3911 1 0.5
Giardia lamblia Hypothetical protein 0.0931 0 0.5
Echinococcus multilocularis alkaline phosphatase, intestinal, gene 2 0.3911 1 0.5
Schistosoma mansoni 23-cyclic-nucleotide 2-phosphodiesterase 0.2271 0.4497 0.1272
Echinococcus granulosus alkaline phosphatase intestinal gene 2 0.3911 1 0.5
Schistosoma mansoni alkaline phosphatase 0.3911 1 1
Treponema pallidum 5'-nucleotidase (ushA) 0.2278 0.4519 0.5
Toxoplasma gondii 5'-nucleotidase, C-terminal domain-containing protein 0.2278 0.4519 1
Schistosoma mansoni alkaline phosphatase 0.3911 1 1
Echinococcus multilocularis intestinal type alkaline phosphatase 1 0.3911 1 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 2.6 uM Inhibition of recombinant ERAP1 (unknown origin) expressed in baculovirus-infected Hi5 insect cells assessed as L-Leucine-7-amido-4-methyl coumarin hydrolysis to 7-amido-4-methyl coumarin after 5 to 10 mins by fluorescence assay ChEMBL. 23916253
IC50 (binding) = 6 uM Inhibition of human recombinant IRAP expressed in HeLa cells assessed as L-Leucine-7-amido-4-methyl coumarin hydrolysis to 7-amido-4-methyl coumarin after 5 to 10 mins by fluorescence assay ChEMBL. 23916253
IC50 (binding) = 8.9 uM Inhibition of recombinant ERAP2 (unknown origin) expressed in baculovirus-infected Hi5 insect cells assessed as L-Arginyl-7-amido-4-methyl coumarin hydrolysis to 7-amido-4-methyl coumarin after 5 to 10 mins by fluorescence assay ChEMBL. 23916253

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.